Tapentadol Immediate Release Tablets Approved For The Treatment Of Moderate To Severe Pain By FDA

Grunenthal GmbH announces that the U.S. Food and Drug Administration (FDA) has approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain for adults 18 years and older. The New Drug Application (NDA) had been submitted to the FDA by Grunenthal’s partner for developing and commercializing tapentadol in the USA, Canada, and Japan, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD), on January 23rd, 2008.

More: continued here

Filed under: Pain / Anesthetics on December 2nd, 2008